These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 14679784

  • 1. [The present status of convergence in PSA reference values--from the surveillance in the Tokai-Hokuriku district].
    Furuta N, Takemura M, Ohta H, Akiyama M, Seishima M.
    Rinsho Byori; 2003 Nov; 51(11):1068-72. PubMed ID: 14679784
    [Abstract] [Full Text] [Related]

  • 2. [Progress in standardization of total PSA immunoassays].
    Ishibashi M.
    Rinsho Byori; 2004 Jul; 52(7):618-24. PubMed ID: 15344562
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Measurement of prostate specific antigen complexed to alpha1-antichymotrypsin to avoid unnecessary biopsy in patients with serum prostate specific antigen levels 4-20 ng/mL.
    Nakano Y, Okamura K, Takamura S, Okamoto N, Narishima M, Yoshino Y, Hattori R, Ono Y, Ohshima S, Nagasaka T.
    Int J Urol; 2005 Aug; 12(8):721-7. PubMed ID: 16174045
    [Abstract] [Full Text] [Related]

  • 7. Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease.
    Mikolajczyk SD, Rittenhouse HG.
    Rinsho Byori; 2004 Mar; 52(3):223-30. PubMed ID: 15137320
    [Abstract] [Full Text] [Related]

  • 8. [Value of prostate specific antigen in early diagnosis of prostatic cancer].
    Xiao LP, Bi XJ, Li YN, Chen XQ, Zhang XF, Yu XP, Liu G, Yang MC, Song Z.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):107-8, 112. PubMed ID: 17259162
    [Abstract] [Full Text] [Related]

  • 9. [Prostate-specific antigen in the diagnosis of prostate cancer in Denmark].
    Andreassen LA, Vondeling H.
    Ugeskr Laeger; 2006 Jan 30; 168(5):475-7. PubMed ID: 16472437
    [Abstract] [Full Text] [Related]

  • 10. [Tumor markers of urinary tract carcinoma].
    Kikuchi H.
    Rinsho Byori; 2004 Apr 30; 52(4):371-80. PubMed ID: 15164607
    [Abstract] [Full Text] [Related]

  • 11. Determination of the relative probability for prostate cancer to avoid unnecessary biopsy.
    Okamura K, Takaba H, Kamihira O, Kinukawa T, Ono Y, Ohshima S, Nagasaka T.
    Int J Urol; 2005 Apr 30; 12(4):346-52. PubMed ID: 15948720
    [Abstract] [Full Text] [Related]

  • 12. [Improvement of total prostate specific antigen(PSA) assay from the "Skewed molar-response" to the "Equimolar-response" by utilizing anti free-PSA monoclonal antibodies].
    Kimura E, Matsumoto K, Samori T.
    Rinsho Byori; 2002 Feb 30; 50(2):202-6. PubMed ID: 11925860
    [Abstract] [Full Text] [Related]

  • 13. [Standardization of PSA assays].
    Kuriyama M.
    Nihon Rinsho; 1998 Aug 30; 56(8):1998-2002. PubMed ID: 9750495
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of prostate-specific antigen and vitamin D in peritoneal dialysis patients.
    Passadakis P, Ersoy F, Tam P, Memmos D, Siamopoulos K, Ozener C, Akçiçek F, Camsari T, Ates K, Ataman R, Vlachojannis J, Dombros N, Utas C, Akpolat T, Bozfakioglu S, Wu GG, Karayaylali I, Arinsoy T, Stathakis C, Yavuz M, Tsakiris D, Dimitriades A, Yilmaz ME, Gültekin M, Karayalçin B, Challa A, Polat N, Oreopoulos DG.
    Adv Perit Dial; 2004 Aug 30; 20():203-8. PubMed ID: 15384827
    [Abstract] [Full Text] [Related]

  • 15. [Advancements in PSA-based screening for prostate cancer].
    Ito K.
    Rinsho Byori; 2004 Jul 30; 52(7):611-7. PubMed ID: 15344561
    [Abstract] [Full Text] [Related]

  • 16. Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients.
    Beneduce L, Prayer-Galetti T, Giustinian AM, Gallotta A, Betto G, Pagano F, Fassina G.
    Cancer Detect Prev; 2007 Jul 30; 31(5):402-7. PubMed ID: 18035503
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of serum markers for prostate cancer.
    Stenman UH, Abrahamsson PA, Aus G, Lilja H, Bangma C, Hamdy FC, Boccon-Gibod L, Ekman P.
    Scand J Urol Nephrol Suppl; 2005 May 30; (216):64-81. PubMed ID: 16019759
    [Abstract] [Full Text] [Related]

  • 18. [Correct use of prostate-specific antigen in office practice].
    Desfemmes FR, Deligne E, Ghoundale O, Labarthe P, Berlizot P, Houlgatte A.
    Prog Urol; 2008 Jan 30; 18(1):41-5. PubMed ID: 18342155
    [Abstract] [Full Text] [Related]

  • 19. [Combined use of PSA density and free to total PSA ratio for cancer detection from patients with PSA elevations].
    Kawai M, Okajima K, Kobayashi K, Moriyama M.
    Hinyokika Kiyo; 2006 Feb 30; 52(2):113-7. PubMed ID: 16541764
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free: total PSA ratios in a consecutive series of men referred for prostate biopsies.
    Rydén L, Egevad L, Ekman P, Hellström M.
    Scand J Urol Nephrol; 2007 Feb 30; 41(4):302-7. PubMed ID: 17763221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.